Stay updated on IsKia TRIAL: Isa-KRd vs KRd in NDMM Clinical Trial
Sign up to get notified when there's something new on the IsKia TRIAL: Isa-KRd vs KRd in NDMM Clinical Trial page.

Latest updates to the IsKia TRIAL: Isa-KRd vs KRd in NDMM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page displays the IsKia phase III multiple myeloma trial record, comparing Isa-KRd with KRd for patients eligible for autologous stem cell transplantation. It includes eligibility criteria, study locations, treatment plans, outcome measures, and a status of active but not recruiting.SummaryDifference76%

- Check15 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA sitewide notice announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check29 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now returns a 403 Forbidden error, blocking access to the study record while the site header and footer remain visible.SummaryDifference0.5%

Stay in the know with updates to IsKia TRIAL: Isa-KRd vs KRd in NDMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IsKia TRIAL: Isa-KRd vs KRd in NDMM Clinical Trial page.